Activity of Vancomycin and Piperacillin-Tazobactam in combination against Methicillin-Resistant Staphylococcus aureus and VAN-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic infection model.

被引：0
|
作者：
Dilworth, Tom [1 ]
Leonard, Steve [2 ]
Mercier, Renee [3 ]
机构：
[1] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
[2] Northeastern Univ, Sch Pharm, Boston, MA 02115 USA
[3] Univ New Mexico, Albuquerque, NM 87131 USA
来源：
PHARMACOTHERAPY | 2013年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
111E
引用
收藏
页码：E215 / E216
页数：2
相关论文
共 50 条
  • [1] Vancomycin and Piperacillin-Tazobactam Against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model
    Dilworth, Thomas J.
    Leonard, Steve N.
    Vilay, A. Mary
    Mercier, Renee-Claude
    CLINICAL THERAPEUTICS, 2014, 36 (10) : 1334 - 1344
  • [2] Evaluation of Vancomycin in Combination with Piperacillin-Tazobactam or Oxacillin against Clinical Methicillin-Resistant Staphylococcus aureus Isolates and Vancomycin-Intermediate S. aureus Isolates In Vitro
    Dilworth, Thomas J.
    Sliwinski, Jora
    Ryan, Keenan
    Dodd, Monique
    Mercier, Renee-Claude
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1028 - 1033
  • [3] Pharmacodynamic (PD) activity of ceftobiprole (Cefto) compared to vancomycin (Vanco) vs. methicillin-resistant Staphylococcus aureus, vancomycin intermediate Staphylococcus aureus and vancomycin resistant Staphylococcus aureus using an in vitro model
    Zhanel, G.
    Voth, D.
    Karlowsky, J.
    Decorby, M.
    Noreddin, A.
    Hoban, D.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 : S27 - S28
  • [4] The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model
    Turner, J
    Howe, RA
    Wootton, M
    Bowker, KE
    Holt, HA
    Salisbury, V
    Bennett, PM
    Walsh, TR
    MacGowan, AP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (05) : 727 - 730
  • [5] Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model
    Zhanel, George G.
    Voth, Dylan
    Nichol, Kim
    Karlowsky, James A.
    Noreddin, Ayman M.
    Hoban, Daryl J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (02) : 364 - 369
  • [6] Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations
    Leonard, Steven N.
    Rybak, Michael J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (01) : 155 - 160
  • [7] Evaluation of Ceftaroline Activity against Heteroresistant Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Intermediate Methicillin-Resistant S-aureus Strains in an In Vitro Pharmacokinetic/Pharmacodynamic Model: Exploring the "Seesaw Effect"
    Werth, Brian J.
    Steed, Molly E.
    Kaatz, Glenn W.
    Rybak, Michael J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) : 2664 - 2668
  • [8] In Vitro Pharmacodynamics of Vancomycin and Cefazolin Alone and in Combination against Methicillin-Resistant Staphylococcus aureus
    Hagihara, Mao
    Wiskirchen, Dora E.
    Kuti, Joseph L.
    Nicolau, David P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (01) : 202 - 207
  • [9] Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus among Methicillin-Resistant Staphylococcus aureus
    Chaudhary, Bajarangi Lal
    Bisht, Dakshina
    Faujdar, Sameer
    ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2022, 14 (01) : 16 - 20
  • [10] Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model
    Huang, VH
    Rybak, MJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) : 302 - 308
12345